<DOC>
	<DOCNO>NCT02790736</DOCNO>
	<brief_summary>The study test efficacy propranolol placebo , administer retrieval previously acquire public speaking fear , reduce fear avoidance public speaking .</brief_summary>
	<brief_title>Brief Intervention Reduce Fear Public Speaking</brief_title>
	<detailed_description>Twenty subject Performance-Only type Social Anxiety Disorder enrol study . Participants complete baseline assessment fear avoidance public speaking . Participants randomly assign single dose propranolol 40mg placebo , administer immediately fear activation procedure . Primary outcome assessment self-reported fear public speaking avoidance behavior behavioral avoidance task 2 week intervention .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Principal Diagnosis Social Anxiety Disorder , Performance type Has clinically significant fear public speaking Physically healthy History serious psychiatric disorder Current Major Depressive Disorder Women pregnant nursing Current use psychiatric medication Persons plan start another treatment study period . Any significant medical condition might increase risk participation use medication might negatively interact propranolol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>propranolol</keyword>
	<keyword>public speaking anxiety</keyword>
</DOC>